Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3VM1001 Cream for Knee Osteoarthritis Pain
NCT02332148Phase 1Unknown
- Sponsor
- CDA Research Group
- Start
- Feb 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules, Drug Delivery Systems
01
Overview
Phase 1, randomised, double-blind trial in knee osteoarthritis (OA) comparing 3VM1001 with Placebo (2 arms). Primary endpoint: Time-averaged change in pain from baseline in a standard visual analog scale at 30 days. Status: unknown.
02
Drugs
3VM1001
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02332148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02332148.